Keros Therapeutics, Inc. (KROS)

11.72 +0.01 (+0.09%) USD  |  NASDAQ  |  Apr 16, 16:00
11.80 +0.08 (+0.68%) After-Hours: 20:00
More

Keros Therapeutics FCF to Assets (TTM)

FCF to Assets (TTM) Chart

View FCF to Assets (TTM) for KROS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View FCF to Assets (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

FCF to Assets (TTM) Range, Past 5 Years

View FCF to Assets (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

FCF to Assets (TTM) Benchmarks

View FCF to Assets (TTM) Benchmarks
Start Trial
Sarepta Therapeutics, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
MannKind Corp. Upgrade
PTC Therapeutics, Inc. Upgrade
Insmed, Inc. Upgrade